Study details
Enrolling now
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
Suvankar Majumdar
NCT IDNCT06635902ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
99
Study length
about 4.3 years
Ages
4–21
Locations
1 site in DC
About this study
Researchers are testing if intravenous L-citrulline helps treat acute pain episodes in people with sickle cell disease. The trial also aims to learn about the safety of this treatment and how it affects participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take L-citrulline
PhasePhase 2
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug routes
oral (Oral Capsule)
Endpoints
Secondary: Opioid consumption, Pain scores, Safety